The Company's ordinary shares are listed on AIM, a market operated by the London Stock Exchange, under the symbol “AREC”. The Company is not listed on any other exchanges or trading platforms.

View

Arecor Therapeutics Annual Report and Accounts 2022

4 May 2023

View

Arecor Therapeutics Form of Proxy

4 May 2023

View

Arecor Therapeutics Notice of AGM

4 May 2023

Major shareholders

BGF Investment Management Limited

12.28%

Unilever*

9.57%

Calculus Funds*

7.92%

Downing LLP*

5.66%

Lombard Odier Asset Management (Europe) Limited

5.64%

Oxford Technology 2 VCT plc

5.19%

Stewart Newton

4.72%

Chelverton Asset Management

4.65%

The Wood family

4.19%

Albion Capital Funds*

4.05%

Unicorn AIM VCT

3.92%

Sarah Howell

2.83%

Amati AIM VCT

2.76%

The number of shares in issue: 30,625,654
Percentage of shares not in public hands: c. 65.8%
Last reviewed and updated: 8 June 2023


* Total numbers are the aggregate amounts held

Constitutional Documents

Date Title View

2 June 2021

Articles of Association

1 June 2021

Admission Document